Literature DB >> 29039233

The relationships of classic psychedelic use with criminal behavior in the United States adult population.

Peter S Hendricks1, Michael Scott Crawford1, Karen L Cropsey2, Heith Copes3, N Wiles Sweat1, Zach Walsh4, Gregory Pavela1.   

Abstract

Criminal behavior exacts a large toll on society and is resistant to intervention. Some evidence suggests classic psychedelics may inhibit criminal behavior, but the extent of these effects has not been comprehensively explored. In this study, we tested the relationships of classic psychedelic use and psilocybin use per se with criminal behavior among over 480,000 United States adult respondents pooled from the last 13 available years of the National Survey on Drug Use and Health (2002 through 2014) while controlling for numerous covariates. Lifetime classic psychedelic use was associated with a reduced odds of past year larceny/theft (aOR = 0.73 (0.65-0.83)), past year assault (aOR = 0.88 (0.80-0.97)), past year arrest for a property crime (aOR = 0.78 (0.65-0.95)), and past year arrest for a violent crime (aOR = 0.82 (0.70-0.97)). In contrast, lifetime illicit use of other drugs was, by and large, associated with an increased odds of these outcomes. Lifetime classic psychedelic use, like lifetime illicit use of almost all other substances, was associated with an increased odds of past year drug distribution. Results were consistent with a protective effect of psilocybin for antisocial criminal behavior. These findings contribute to a compelling rationale for the initiation of clinical research with classic psychedelics, including psilocybin, in forensic settings.

Entities:  

Keywords:  Hallucinogen; criminal justice; forensic psychology; lysergic acid diethylamide; psilocybin; psychedelic; recidivism

Mesh:

Substances:

Year:  2017        PMID: 29039233     DOI: 10.1177/0269881117735685

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

1.  Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings.

Authors:  Matthias Forstmann; Daniel A Yudkin; Annayah M B Prosser; S Megan Heller; Molly J Crockett
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-21       Impact factor: 11.205

2.  Risk factors for recidivism in individuals receiving community sentences: a systematic review and meta-analysis.

Authors:  Denis Yukhnenko; Nigel Blackwood; Seena Fazel
Journal:  CNS Spectr       Date:  2019-06-20       Impact factor: 3.790

Review 3.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

4.  Ancient Roots of Today's Emerging Renaissance in Psychedelic Medicine.

Authors:  Daniel R George; Ryan Hanson; Darryl Wilkinson; Albert Garcia-Romeu
Journal:  Cult Med Psychiatry       Date:  2021-09-02

5.  Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.

Authors:  James D Sexton; Charles D Nichols; Peter S Hendricks
Journal:  Front Psychiatry       Date:  2020-02-11       Impact factor: 4.157

6.  Associations between lifetime classic psychedelic use and markers of physical health.

Authors:  Otto Simonsson; James D Sexton; Peter S Hendricks
Journal:  J Psychopharmacol       Date:  2021-03-09       Impact factor: 4.153

7.  Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.

Authors:  Grant M Jones; Matthew K Nock
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.996

8.  Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.

Authors:  Christin Mellner; Micael Dahlen; Otto Simonsson
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

Review 9.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

10.  Predicting Responses to Psychedelics: A Prospective Study.

Authors:  Eline C H M Haijen; Mendel Kaelen; Leor Roseman; Christopher Timmermann; Hannes Kettner; Suzanne Russ; David Nutt; Richard E Daws; Adam D G Hampshire; Romy Lorenz; Robin L Carhart-Harris
Journal:  Front Pharmacol       Date:  2018-11-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.